Discovery & Development

Why virtual and augmented reality technologies are the future of workforce training.

What’s on the horizon for the field of nanomedicine?

Jeroen den Hertog from the Hubrecht Institute is exploring the bioactive properties of fungal strains.

A novel small molecule aims to tackle both Alzheimer’s disease and Dravet syndrome.

Dale Thomas, Co-founder of Mytide, explains how AI can be used for the discovery and development of peptide therapeutics.

As the new virus spreads, more information is needed to mount an appropriate response.

Bacteria shredding liquid metals to fight drug-resistant superbugs.

Can open source by applied to pharma R&D? This is the aim of Molecule.

A new computational tool could help improve the stability and predictability of ADCs.

How will inhaled therapies evolve? Lei Mao at Recipharm gives his take on the future of these therapies.